US 11525629
Target residual moisture content for lyophilized drug product
granted A61KA61K9/19
Quick answer
US patent 11525629 (Target residual moisture content for lyophilized drug product) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K9/19